Counterpoint Mutual Funds’s Labcorp LH Stock Holding History

Counterpoint Mutual Funds’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-675	Closed	-$137K	–	418
2022 Q4	$137K	Buy	+675	New	+$132K	0.14%	162

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Counterpoint Mutual Funds's LH Position: Q1 2023 in Review

Counterpoint Mutual Funds sold out of Labcorp (LH) in Q1 2023, closing a stake of 675 shares — an estimated $137K sold.

Counterpoint Mutual Funds first reported a position in LH in Q4 2022 and held it in 1 quarter. The position peaked at $137K in Q4 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Counterpoint Mutual Funds reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Counterpoint Mutual Funds sold 675 Labcorp shares in Q1 2023, an estimated $137K.
Counterpoint Mutual Funds first reported a position in Labcorp in Q4 2022 and held it in 1 quarter.
Counterpoint Mutual Funds's Labcorp position peaked at $137K in Q4 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2023, filed 20 Apr 2023.